8176 - 8200 of 8399 Results
Title
Year
-
OPENTitle: Mitochondrial therapies for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22781Best OA location URL: https://europepmc.org/articles/pmc5797696?pdf=renderCitation Count: 58
- New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease2010RESTRICTEDTitle: New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22636Citation Count: 44
- Role of serotonin neurons in the induction of levodopa‐ and graft‐induced dyskinesias in Parkinson's disease2010RESTRICTEDTitle: Role of serotonin neurons in the induction of levodopa‐ and graft‐induced dyskinesias in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22792Citation Count: 74
-
RESTRICTEDTitle: The antipsychotic potential of muscarinic allosteric modulationJournal Name: Drug News & PerspectivesPublisher: PorticoVol: 23Issue #: 4Start Page: 229End Page: 229Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1358/dnp.2010.23.4.1416977Best OA location URL: https://europepmc.org/articles/pmc4780339?pdf=renderCitation Count: 55
-
OPENTitle: Therapeutic directions for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22790Best OA location URL: https://europepmc.org/articles/pmc3110693?pdf=renderCitation Count: 7
- α-Synuclein Gene May Interact with Environmental Factors in Increasing Risk of Parkinson’s Disease2010OPENTitle: α-Synuclein Gene May Interact with Environmental Factors in Increasing Risk of Parkinson’s DiseaseJournal Name: NeuroepidemiologyPublisher: S. Karger AGVol: 35Issue #: 3Start Page: 191End Page: 195Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000315157Best OA location URL: https://europepmc.org/articles/pmc2945263?pdf=renderCitation Count: 61
- Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson’s disease models2009OPENTitle: Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson’s disease modelsJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 3Issue #: 3-4Start Page: 194End Page: 208Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1242/dmm.004267Best OA location URL: https://dspace.mit.edu/bitstream/1721.1/66913/1/SuetalDMM09.pdfCitation Count: 178
- Sensitivity and specificity of the finger tapping task for the detection of psychogenic movement disorders2009OPENTitle: Sensitivity and specificity of the finger tapping task for the detection of psychogenic movement disordersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 16Issue #: 3Start Page: 197End Page: 201Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2009.11.007Best OA location URL: https://europepmc.org/articles/pmc2829355?pdf=renderCitation Count: 30
- Comparative Transduction Efficiency of AAV Vector Serotypes 1–6 in the Substantia Nigra and Striatum of the Primate Brain2009OPENTitle: Comparative Transduction Efficiency of AAV Vector Serotypes 1–6 in the Substantia Nigra and Striatum of the Primate BrainJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 18Issue #: 3Start Page: 588End Page: 593Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2009.286Best OA location URL: http://www.cell.com/article/S1525001616323085/pdfCitation Count: 125
- Are there differences in cerebral white matter lesion burdens between Parkinson’s disease patients with or without dementia?2009OPENTitle: Are there differences in cerebral white matter lesion burdens between Parkinson’s disease patients with or without dementia?Journal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 119Issue #: 1Start Page: 147End Page: 149Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-009-0620-2Best OA location URL: https://europepmc.org/articles/pmc2928051?pdf=renderCitation Count: 45
- Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease2009OPENTitle: Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s DiseaseJournal Name: Neurotoxicity ResearchPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page: 63End Page: 72Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12640-009-9140-zBest OA location URL: https://europepmc.org/articles/pmc3603276?pdf=renderCitation Count: 234
-
RESTRICTEDTitle: Glutamate Receptors as Therapeutic Targets for Parkinsons DiseaseJournal Name: CNS & Neurological Disorders - Drug TargetsPublisher: Bentham Science Publishers Ltd.Vol: 8Issue #: 6Start Page: 475End Page: 491Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/187152709789824606Best OA location URL: https://europepmc.org/articles/pmc3005251?pdf=renderCitation Count: 223
- Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North Africa2009OPENTitle: Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North AfricaJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 477Issue #: 2Start Page: 57End Page: 60Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2009.11.066Best OA location URL: https://europepmc.org/articles/pmc2970621?pdf=renderCitation Count: 25
- Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathways2009OPENTitle: Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathwaysJournal Name: SynapsePublisher: WileyVol: 64Issue #: 3Start Page: 251End Page: 266Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/syn.20725Best OA location URL: https://europepmc.org/articles/pmc3821045?pdf=renderCitation Count: 21
-
OPENTitle: Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer’s diseaseJournal Name: BiomarkersPublisher: Informa UK LimitedVol: 14Issue #: 7Start Page: 493End Page: 501Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3109/13547500903108423Best OA location URL: https://europepmc.org/articles/pmc2824250?pdf=renderCitation Count: 107
-
RESTRICTEDTitle: LRRK2 in Parkinson’s disease: function in cells and neurodegenerationJournal Name: The FEBS JournalPublisher: WileyVol: 276Issue #: 22Start Page: 6436End Page: 6444Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1742-4658.2009.07342.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-4658.2009.07342.xCitation Count: 32
-
RESTRICTEDTitle: LRRK2 in Parkinson’s disease: in vivo models and approaches for understanding pathogenic rolesJournal Name: The FEBS JournalPublisher: WileyVol: 276Issue #: 22Start Page: 6445End Page: 6454Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1742-4658.2009.07343.xBest OA location URL: https://europepmc.org/articles/pmc2827245?pdf=renderCitation Count: 21
- VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease2009OPENTitle: VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 37Issue #: 2Start Page: 330End Page: 338Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2009.10.011Best OA location URL: https://europepmc.org/articles/pmc2818321?pdf=renderCitation Count: 74
-
OPENTitle: Safety and tolerability of putaminal AADC gene therapy for Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 73Issue #: 20Start Page: 1662End Page: 1669Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3181c29356Best OA location URL: https://europepmc.org/articles/pmc2839805?pdf=renderCitation Count: 403
- Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: Cross-talk between E3s in the endoplasmic reticulum2009OPENTitle: Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: Cross-talk between E3s in the endoplasmic reticulumJournal Name: Biochemical and Biophysical Research CommunicationsPublisher: Elsevier BVVol: 390Issue #: 3Start Page: 758End Page: 762Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbrc.2009.10.045Best OA location URL: https://europepmc.org/articles/pmc3014991?pdf=renderCitation Count: 54
- MitoPark mice mirror the slow progression of key symptoms and L‐DOPA response in Parkinson's disease2009OPENTitle: MitoPark mice mirror the slow progression of key symptoms and L‐DOPA response in Parkinson's diseaseJournal Name: Genes, Brain and BehaviorPublisher: WileyVol: 9Issue #: 2Start Page: 173End Page: 181Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1601-183x.2009.00542.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1601-183X.2009.00542.xCitation Count: 101
- Compacted DNA Nanoparticle Gene Transfer of GDNF to the Rat Striatum Enhances the Survival of Grafted Fetal Dopamine Neurons2009OPENTitle: Compacted DNA Nanoparticle Gene Transfer of GDNF to the Rat Striatum Enhances the Survival of Grafted Fetal Dopamine NeuronsJournal Name: Cell TransplantationPublisher: SAGE PublicationsVol: 18Issue #: 10-11Start Page: 1183End Page: 1196Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3727/096368909x12483162196881Best OA location URL: https://journals.sagepub.com/doi/pdf/10.3727/096368909X12483162196881Citation Count: 72
-
OPENTitle: Genetic interaction between Lrp6 and Wnt5a during mouse developmentJournal Name: Developmental DynamicsPublisher: WileyVol: 239Issue #: 1Start Page: 237End Page: 245Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.1002/dvdy.22101Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/dvdy.22101Citation Count: 32
- Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons2009OPENTitle: Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neuronsJournal Name: Journal of NeurochemistryPublisher: WileyVol: 111Issue #: 5Start Page: 1202End Page: 1212Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2009.06404.xBest OA location URL: https://europepmc.org/articles/pmc4896488?pdf=renderCitation Count: 58
-
RESTRICTEDTitle: Genomewide association study for onset age in Parkinson diseaseJournal Name: BMC Medical GeneticsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/1471-2350-10-98Best OA location URL: https://bmcmedgenet.biomedcentral.com/counter/pdf/10.1186/1471-2350-10-98Citation Count: 107